The Finnish Society of Clinical Pharmacology has a great pleasure to invite you to the second Nordic Conference on Personalized Medicine (NORPM2023) in Turku, Finland, from 14th to 16th June 2023. This three-day conference will bring together outstanding Nordic and international scientists to promote research and implementation of personalized medicine. The target group for the … Read more
2-7 July 2023 Glasgow, Scotland Call for late-breaking abstracts now open – SUBMIT AN ABSTRACT HERE Deadline: Tuesday, 14 February 2023
(largely inspired by the obituary published by his daughter Emma Thompson in The Guardian, 29 Jul 2022https://www.theguardian.com/education/2022/jul/29/donald-singer-obituary) Our dear colleague and friend Donald Singer died aged 67 of a cardiac arrest in July 2022. Donald was born in Forres, North-East of Inverness, Scotland. He did his medical training at the Universityof Aberdeen, and completed his … Read more
The war in Ukraine has led to tremendous medical problems and need for support with medication, including need for information to avoid medication related problems. The European Association for Clinical Pharmacology represents the Clinical Pharmacology Societies from 29 countries in Europe (with members mostly from academia, partly from industry and regulation). As a European umbrella … Read more
The abstract submission deadline has been postponed to 1 March.
See the latest version of the EACPT 2022 programme.
Please find a warning message by EMA drawing our attention to the potential drug-drug interactions with ritonavir contained in Paxlovid.
The Finnish Society of Clinical Pharmacology (FSCP) and University of Helsinki organised a two-day scientific symposium to honour the late professor Pertti J. Neuvonen.
Photo: ©Ida Pimenoff/University of Helsinki
The EACPT wishes you all a very MERRY CHRISTMAS and a HAPPY AND PROSPEROUS NEW YEAR! We look forward to welcoming you in Athens in June. Pierre Marquet, Chair on behalf of the Executive Committee
Article: “Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study”. The Lancet, 2020, vol 395, pages 1705-1714